Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

  • Showing results for a modified search because your search retrieved no results.
1.

Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes.

Mooranian A, Zamani N, Takechi R, Al-Sallami H, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S748-S754. doi: 10.1080/21691401.2018.1511572. Epub 2018 Nov 13.

PMID:
30422681
2.

Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses.

Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S741-S747. doi: 10.1080/21691401.2018.1511571. Epub 2018 Sep 27.

PMID:
30260253
3.

In-Doped ZnO Hexagonal Stepped Nanorods and Nanodisks as Potential Scaffold for Highly-Sensitive Phenyl Hydrazine Chemical Sensors.

Umar A, Kim SH, Kumar R, Al-Assiri MS, Al-Salami AE, Ibrahim AA, Baskoutas S.

Materials (Basel). 2017 Nov 21;10(11). pii: E1337. doi: 10.3390/ma10111337.

4.

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.

Negrulj R, Mooranian A, Chen-Tan N, Al-Sallami HS, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Arfuso F, Al-Salami H.

Artif Cells Nanomed Biotechnol. 2016 Aug;44(5):1290-7. doi: 10.3109/21691401.2015.1024845. Epub 2015 Mar 26.

PMID:
25811999
5.

Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.

Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Arfuso F, Jones F, Al-Salami H.

Artif Cells Nanomed Biotechnol. 2016;44(2):588-95. doi: 10.3109/21691401.2014.971806. Epub 2014 Oct 30.

PMID:
25358121
6.

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats.

Al-Salami H, Butt G, Tucker I, Fawcett PJ, Golocorbin-Kon S, Mikov I, Mikov M.

Eur J Drug Metab Pharmacokinet. 2009 Jan-Mar;34(1):43-50.

PMID:
19462928

Supplemental Content

Loading ...
Support Center